PEER TO PEER

SABCS 2024

Physician’s Weekly-created content featuring key opinion leaders sharing their perspectives on eBC & mBC from different vantage points at SABCS 2024.

Big genomic data visualization. DNA test, genom map

Improving Tailored Treatment Plans in HR+, HER2- Early Breast Cancer

Genomic profiling in the FLEX trial predicted chemotherapy response in HR+, HER2- breast cancer, which could enable tailored treatment plans.

READ THE STORY

Dec 20, 2024

Dr. Justin Balko on Challenges & Emerging Biomarkers in Breast Cancer

Justin Balko, PharmD, PhD, reviews his session from SABCS 2024 where he discussed the challenges and advancements in immunotherapy for early-stage triple-negative breast cancer (TNBC). Additionally, he discusses the importance of identifying predictive biomarkers to optimize treatment and improve patient quality of life.

Dec 19, 2024

Doctor mammologist examines woman breasts and lymph nodes. Correcting the shape of the breast - lift, reduction, reconstruction, augmentation. Problems of lactation. Breast cancer. lymph node, sentinel

Semi-Dry Dot-Blot Kit Detects Macrometastases in Patients With Breast Cancer

Physician’s Weekly spoke with Dr. Otsubo and Dr. Hara about their research and how they anticipate the SDB kit will be applied in clinical settings.

Dec 17, 2024

Exploring Immune Biomarkers and Tumor-Infiltrating Lymphocytes With Dr. Justin Balko

Justin Balko, PharmD, PhD, recently joined Dr. Priyanka Sharma and Dr. Roberto Salgado at the 2024 San Antonio Breast Cancer Symposium to discuss immune biomarkers, including tumor-infiltrating lymphocytes, and their roles.

Dec 16, 2024

Which Factors Influence Biopsy Approach & Therapy Sequence in Metastatic ER+ Breast Cancer?

Dr. Marla Lipsyc-Sharf reviews her recent session at the 2024 SABCS meeting, discussing biopsy approaches and treatment sequencing in metastatic breast cancer.

Dec 12, 2024

PW QUIZ

Follow Us